Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies

Ann N Y Acad Sci. 2000:922:345-8. doi: 10.1111/j.1749-6632.2000.tb07061.x.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Camptothecin / administration & dosage
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Synergism
  • Humans
  • Neoplasms / drug therapy*

Substances

  • rubitecan
  • Cisplatin
  • Camptothecin